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Proceedings of Science in the House
5th Annual Science in the House Exhibition
David C. Magri∗1
Celebrating its 5th anniversary, this year’s Science in
the House exhibition was a most memorable occasion.
The event was held on Thursday 29th September at
11:00 am in the main foyer of the Parliament Building in
Valletta. The event commenced with opening remarks
from Prof. Alex Felice, chairman of the Science in the
City/European Researchers’ Night consortium followed
by a distinguished list of speakers including Prof. Al-
fred Vella, Rector of the University of Malta, the Hon.
Evarist Bartolo M.P., Minister for Education and Em-
ployment, and the Hon. Ang˙lu Farrugia M.P., Speaker
of the House of Representatives, Parliament of Malta.
This year’s event showcased a selection of research
projects on neuroscience and brain research in addi-
tion to the regular compliment of posters from across
various research disciplines. A set of four posters on
the neuroscience theme presented research on the use
of stereo-electroencephalography (EEG), the treatment
of epilepsy with light, biochemical studies of autism
and research related to depression, addition and epi-
lepsy. These studies involve collaborations between
Prof. Giuseppe Di Giovanni and colleagues from other
institutions including Prof. Giacomo Rizzolatti, Dr
Fausto Caruana, Prof. Vincenzo Crunelli and Dr Maria
Cristina D’Adamo.
The University of Malta is fortunate to have a deep
roster of neuroscience and brain research experts. An-
other column of four posters showcased projects by Prof.
Neville Vassallo, Prof. Mario Valentino, Dr Ruben Cau-
chi and Prof. Richard Muscat on the discovery of new
drugs for Alzheimer’s and Parkinson’s diseases, in vivo
imaging of astrocytes, the use of genetically modified
fruit flies for studying motor neuron disease and the
study of neural brain function and oscillation, respect-
ively.
New this year, biographical posters of 4 Maltese schol-
ars from the past and present who have contributed sig-
nificantly to the field of cognitive science and neuros-
cience were part of the opening ceremony. The bio-
graphical posters of Prof. Louis Vassallo (medicine),
Prof. George Xuereb (pathology, former Rector), Prof.
Edward de Bono (inventor of the concept of lateral
thinking) and Prof. Ludwig Zrinzo (neurosurgery) were
accompanied by the physical presence of Prof. de Bono
and Prof. Zrinzo. Family members of the late Prof.
Vassallo and late Prof. George Xuereb were also in at-
tendance for the ceremony.
Representation of various research projects came from
the Faculties of Science, Medicine and Surgery, Health
Sciences and Economics, Management & Accountancy.
Topics ranged from electromagnetic fields in medicine,
evaluation of earthquake risk on the Maltese Islands, the
economics and politics of household recycling, zebrafish
as an animal model for studying bone diseases, novel hy-
brid optomechanical technologies, human foraging and
attention, yeast cell cycle studies with aspirin and ge-
netic studies of type II diabetes. In addition, this year
the exhibition also included posters from four research-
oriented organisations: Malta Life Science Park; Malta
College of Arts Science and Technology (MCAST); Re-
search, Innovation and Development Trust (RIDT) and
the Malta Medicines Authority.
The exhibition remained on display for public viewing
the following Friday and Saturday evenings for the Sci-
ence in the City/European Researchers’ Night and Notte
Bianca festivals, respectively. The exhibition was left on
display for the general public and parliamentarians for
another week afterwards.
Science in the House is organised by the Malta Cham-
ber of Scientists, the RIDT and the Science in the
City/European Researchers’ Night consortium and part
funded by the EU Marie Sk lodowska-Curie Action of
the Horizon 2020 (H2020) Programme. More informa-
tion can be found at www.scienceinthecity.org.mt or at
www.facebook.com/ScienceInTheCityMalta.
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Figure 1: Guests during the opening remarks of Science in the
House during the speech of the Hon. Evarist Bartolo. In the front
row from left to right are Prof. Alfred Vella, the Hon. Ang˙lu
Farrugia, Speaker of the House, the Hon. Helena Dalli and Prof.
Alex Felice and the Hon. Chris Agius (second row to the right).
Figure 2: The main foyer of the Parliament Building showcasing
the exhibition before the commencement of the 5th annual Science
in the House exhibition.
2016 Science in the House Posters by
Title and Contributing Researchers
1. Electromagnetic Fields in Medicine – Prof. Charles
Sammut, Prof. Pierre Schembri-Wismayer, Dr
Lourdes Farrugia, Iman Farhat, Julian Bonello
2. Evaluation of Earthquake Risk on the Maltese
Islands – Prof. Pauline Galea, Dr Sebastiano
D’Amico, George Bozionelo, Daniela Farrugia
3. Human Foraging and Attention – Prof. Ian
Thornton, Marcello Go´mez Maureira, Marthese
Borg, Amanda Muscat
4. Zebrafish as an Animal Model for Studying Bone
Diseases – Prof. Angela Xuereb, Dr Melissa For-
mosa
5. The Economics and Politics of Voluntary House-
hold Recycling – Dr Marie Briguglio
6. Hybrid Optomechanical Technologies – Dr Andre´
Xuereb, Vittorio Peano
7. The Genetic Epidemiology of Type 2 Diabetes –
Prof. Josanne Vassallo, Dr Nikolai Pace, Seham
Eljali
8. The Cell Cycle is Crucial for Cell Survival and
Death – Prof. Rena Balzan, Dr Gianluca Farru-
gia, Maria Azzopardi
9. Discovering New Drugs for Alzheimer’s and Par-
kinson’s Diseases – Dr Neville Vassallo, Stephanie
Ghio
10. In Vivo Imaging and Monitoring Astrocytes in
Health and Disease – Prof. Mario Valentino, Dr
Christian Zammit, Robert Zammit
11. Genetically Modified Fruit Flies to Untangle Mys-
teries of Motor Neuron Disease – Dr Ruben Cauchi,
Michelle Briffa, Rebecca Cacciottolo, Rebecca Borg
12. Brain Function and Neural Oscillations – Prof.
Richard Muscat, Nowell Zammit
13. Decomposing tool action observation by sEEG –
Prof. Giacomo Rizzolatti, Dr Fausto Caruana
14. Treating Epilepsy with Light – Prof. Vincenzo
Crunelli
15. Autism Spectrum Disorder with Intellectual Disab-
ility – Dr Maria Cristina D’Adamo
16. Curing Depression, Addiction and Epilepsy – Prof.
Giuseppe Di Giovanni
17. Malta Life Sciences Park – Dr Joseph Sammut
18. MCAST Water Research and Training Centre – Dr
Alex Rizzo
19. Research, Innovation and Development Trust
(RIDT) – Wilfred Kenely
20. Malta Medicines Authority – Prof. Anthony Serra-
cino Inglott
Gratitude is extended to C. Camilleri & Sons for cater-
ing, Pierre Mallia, Director, House of Representatives,
and Ryan Cutajar and Gianni Zammit of JugsMalta for
logistic support, Siobhan Vassallo for the poster design,
Angele Galea for assistance with the biography poster
exhibition and individuals who contributed to the insti-
tution posters.
Figure 3: Researchers Lourdes Farrugia (left) and Julian Bon-
ello (second from left), Dr Leonie Baldacchino (middle left) speak-
ing with Prof. Alex Felice (middle right), Hon. Ang˙lu Farrugia
(second from right) and Prof. Charles Sammut, Dean of the Fac-
ulty of Science (right).
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OBJECTIVES OF THE RESEARCH
High-frequency electromagnetic fields (EMF) are used to study the human body, in 
particular the water content in various tissues. Using EMFs we can distinguish cancer 
tumours from healthy tissue as the amount of water in tumours is higher than in 
healthy tissue. The difference in the amount of EMF energy absorbed by healthy and 
cancerous cells allows for therapeutic and diagnostic applications.
MAIN FINDINGS TO DATE
The electrical properties of liver, kidney and muscle tissue are dependent on the 
tissue age. A recent study showed that the properties of the liver measured in vivo 
can be estimated from ex vivo measurements.  Liquids mimicking the electrical 
properties of different organs have been formulated.
SOCIO-ECONOMIC IMPACT
Computational and experimental methods have provided insight into the effect EMF 
has with different organs and tissues in the human body. This research could lead to 
the development of new medical devices and more effective treatments in oncology.
THE RESEARCH TEAM
The research is led by Prof. Charles Sammut of the Department of Physics in 
collaboration with Prof. Pierre Schembri-Wismayer of the Department of Anatomy, 
Dr Lourdes Farrugia of the Department of Physics and postgraduate students Julian 
Bonello and Maik Pertermann at the University of Malta.
ACKNOWLEDGMENT OF RESEARCH SUPPORT
The research is supported by the University of Malta and the European Regional 
Development Fund (ERDF) grants 018 and 310. The research group is involved 
with various COST Actions and collaborates with the National University of Ireland 
in Galway, the Energy and Economic Development (ENEA) in Rome and Supelec, 
University Paris-Sud in France.
ELECTROMAGNETIC
FIELDS IN MEDICINE
OBJECTIVES OF THE RESEARCH
Historical and geological studies indicate that the possibility of serious earthquake 
damage to the Maltese islands is real. Our research aims to evaluate the threat and 
potential damage that could result from earthquakes. Using state-of-the-art seismic 
monitoring systems and virtual regional seismic networks, we are investigating 
known and newly-discovered tectonic features.  New imaging techniques provide 
a way of determining the site-specific amplification of incoming seismic waves and 
hence the surface ground response. The data is used to generate realistic earthquake 
ground motion scenarios for risk-assessment purposes.
MAIN FINDINGS TO DATE
Our research has revealed that the frequency of earthquakes around the Maltese 
islands is much greater than previously thought.  New instrumentation provides 
increased sensitivity for detecting tremors. We have also identified the role that clay 
layers have on site- and frequency-dependent seismic amplification.
SOCIO-ECONOMIC IMPACT
Through collaboration with the civil engineering community, this research will 
influence national strategies for designing and implementing improved construction 
guidelines for safe buildings that take into account the specific local geology. 
A holistic earthquake risk assessment will also provide important inputs to the 
insurance industry and Civil Protection.
THE RESEARCH TEAM
The research is carried out by the Seismic Monitoring and Research Group within the 
Department of Geosciences coordinated by Dr Pauline Galea with team members Dr 
Sebastiano D’Amico, George Bozionelos, Daniela Farrugia, and Dr Matthew Agius in 
collaboration with a number of academic institutions in Europe and America.
ACKNOWLEDGMENT OF RESEARCH SUPPORT
Financial support has come from the SIMIT project (B1-2.19/11, Italia-Malta OP 
2007-2013); Endeavour scholarship; ERDF 310 (Expanding the Physics and Applied 
Interdisciplinary Research Capabilities at the Faculty of Science), COST Actions 
ES1401, ES1301, TU1208 and the University of Malta.
EVALUATION OF 
EARTHQUAKE RISK ON THE 
MALTESE ISLANDS
www.xjenza.org
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OBJECTIVES OF THE RESEARCH
The objective is to use a novel approach to understanding how human perception 
and action is constrained by attention. Inspired by classic animal foraging research, 
we have developed a series of mobile phone apps that are used to collect data from 
diverse groups of human participants in a variety of settings. Here, we present some 
of our main findings and provide demonstrations of our tasks with particular focus 
on a new 3D scenario developed as a collaboration between the Department of 
Cognitive Science and the Institute of Digital Games.
MAIN FINDINGS TO DATE
Our studies suggest that human foraging is tightly constrained by attention. Search 
is flexible when individual items can be easily detected, but becomes more limited 
when viewing conditions deteriorate or attentional load increases. However, some 
individuals (“super-foragers”) do not conform to this pattern. Their behaviour raises 
important questions about current theories of attention.
SOCIO-ECONOMIC IMPACT
Understanding and improving how we search has implications in many areas 
including consumer behaviour, medical image interpretation and airport security 
screening. We are constantly asked to divide our attention (e.g., talking and driving).  
Knowing when we can and cannot do this could save lives. How people control 
attention could shed light on several deficits that affect patient populations.
THE RESEARCH TEAM
The project is led by Prof. Ian Thornton of the University of Malta and Prof. Árni 
Kristjánsson of the University of Iceland, and assisted by two post-doctorate 
researchers based in Iceland, Ómar Jóhannesson and Andrey Chetverikov. In Malta, 
Francesca Borg Taylor-East, Elizabeth Camilleri & Isabelle Kniestedt at the Institute of 
Digital Games have developed a new foraging app.
ACKNOWLEDGMENT OF RESEARCH SUPPORT
Financial support for this project comes from the University of Malta, the Icelandic 
Research Fund (Rannís), the Research Fund of the University of Iceland, the Russian 
Foundation for Basic Research and the Saint Petersburg State University.
HUMAN FORAGING AND 
ATTENTION
OBJECTIVES OF THE RESEARCH
Osteoporosis is a skeletal disease whereby bones become weaker and fragile 
resulting in increased risk of fractures. The disease can be caused by both lifestyle 
factors and genetic traits.  Individuals with a family history of osteoporosis are prone 
to becoming affected at an early age.  Using zebrafish as an animal model, the genes 
that cause osteoporosis are being assessed for their effect on bone development and 
cartilage formation.
MAIN FINDINGS TO DATE
Around 80% of the zebrafish genes are identical to those of humans, making them 
a good animal model.  Therefore, zebrafish can be used to study defects in bone 
and cartilage formation. Genetic studies on Maltese families with multiple affected 
members have led to the identification of new genes that are hypothesised to affect 
bone development.
SOCIO-ECONOMIC IMPACT
Genetic factors play a major role in the susceptibility to osteoporosis. Identifying 
these genetic factors could aid in the early diagnosis of osteoporosis and the 
development of personalised medicine. Preventive measures and early detection 
could prevent unnecessary suffering in high-risk individuals.
THE RESEARCH TEAM
The principal investigators are Prof. Angela Xuereb-Anastasi and Dr Melissa Formosa 
from the University of Malta. The research is conducted in collaboration with Prof. 
André Uitterlinden, Prof. Fernando Rivadeneira, Dr Annemieke Verkerk, and Prof. Rob 
Willemsen from the Erasmus University Medical Centre in Rotterdam.
ACKNOWLEDGMENT OF RESEARCH SUPPORT
The research is supported by the Malta Community Chest Fund in conjunction with 
the Research Innovation and Development Trust (RIDT).
ZEBRAFISH AS AN ANIMAL 
MODEL FOR STUDYING 
BONE DISEASES
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OBJECTIVES OF THE RESEARCH
Municipal solid waste is a by-product of economic production and consumption. Its 
management and mismanagement incurs high capital and running costs, creates 
environmental and health impacts. A remedy imposed in several countries is a 
(polluter pays) tax on household waste disposal. However, the introduction or an 
increase in taxes is politically unpopular – sometimes stimulating illegal disposal. 
Communication campaigns to encourage voluntary cooperation could be a solution, 
although little economic research data is available in this field. 
MAIN FINDINGS TO DATE
Our findings show that households are willing to recycle voluntarily.  Household 
conditions (like space and time) and intervention characteristics (like convenience) 
stimulate voluntary uptake. We have discovered that political preferences influence 
household willingness to cooperate. When there is a negative sentiment towards 
the party in government, households are less willing to participate in government 
sponsored schemes. 
SOCIO-ECONOMIC IMPACT
This research helps policy-makers and scheme-operators to increase household 
participation in recycling. Voluntary cooperation can cultivate public-spirited motives 
and lower the administrative, environmental and political costs of compliance. The 
finding that political preferences influence cooperation will result in better ways in 
which a public-good scheme is communicated to the public and help forecast uptake. 
THE RESEARCH TEAM
The research team consists of Dr Marie Briguglio of the Department of Economics at 
the University of Malta and Prof. Liam Delaney and Prof. Alex Wood of the University 
of Stirling in the UK. 
ACKNOWLEDGMENT OF RESEARCH SUPPORT
The research was conducted at the University of Stirling and part-funded by an Early 
Career Engagement Grant of the Scottish Institute for Research in Economics (SIRE) 
and PhD bursary from the University of Malta.
THE ECONOMICS AND 
POLITICS OF VOLUNTARY 
HOUSEHOLD RECYCLING
OBJECTIVES OF THE RESEARCH
Hybrid Optomechanical Technologies (HOT) are a new kind of sensing and 
information processing technology based on light and motion. Scientists know that 
light, just like water emerging from a hosepipe, can push small things around. This 
concept can be used to control the motion of small objects with light and to measure 
their position very accurately. New devices will be developed that use light and 
motion to store or route information, or make extremely accurate measurements.
MAIN FINDINGS TO DATE
The consortium has demonstrated how to use tiny moving objects to produce diodes 
for light. Such devices allow optical signals to go in one direction from A to B, but 
not vice versa. These technologies may be used to amplify or process optical signals 
inside the computer chips of the future. We have built devices that demonstrate 
quantum entanglement in the vibrations of two microscopic drums. This will answer 
the question of why ordinary objects, like human beings, never seem to behave 
quantum mechanically, like being in two places at once.
SOCIO-ECONOMIC IMPACT
Completely new information processing technologies must be developed for 
computers to keep getting smaller and faster. Technologies using light instead of 
electricity are promising candidates. However, researchers are unsure how ordinary 
computer chips, which use electrical signals, can be developed to process light 
directly. HOT may solve this problem with new technologies that are faster and more 
energy efficient than those currently used today.
THE RESEARCH TEAM
The research team at the University of Malta consists of the Quantum Research 
Group within the Department of Physics in the Faculty of Science. The project is 
led by Dr André Xuereb. The project involves a consortium of 16 other institutions 
including several leading research team from European universities and four 
industrial partners (IBM, Hitachi, ST Microelectronics, and Thales SA).
ACKNOWLEDGMENT OF RESEARCH SUPPORT
HOT is supported by the Horizon 2020 programme of the European Commission. 
It builds on work supported through several private and public research initiatives, 
including the FP7 programme, and COST Action networks. We also acknowledge 
funding from RIDT and MCST.
HYBRID OPTOMECHANICAL 
TECHNOLOGIES
www.xjenza.org
5th Annual Science in the House Exhibition 187
OBJECTIVES OF THE RESEARCH
Type 2 diabetes is a metabolic disease characterised by high blood sugar levels in 
patients. The disease is a major risk factor for the development of cardiovascular 
disease and eventually death. The objective of our research is to explore the 
relationship between select genetic variants and the risk of diabetes. We examine 
DNA from new born babies as a reference and compare healthy senior citizens 
without diabetes to those with diabetes in the Maltese population. Patients from 
Malta and Libya are compared to explore the relationship between genetics and 
clinical traits.
MAIN FINDINGS TO DATE
We have discovered that there are eight candidate genes consistently association 
with occurrence of type 2 diabetes in the Maltese population. These gene variants 
serve functional roles in inflammation, fat cell development and energy expenditure. 
Specific subgroups with diabetes were used for this study to identify any association 
between genetic makeup and body composition. 
SOCIO-ECONOMIC IMPACT
The genetic findings could be potentially used for the early identification of 
individuals at risk of developing type 2 diabetes allowing for preventive measures 
and personalised treatment strategies.  
THE RESEARCH TEAM
The research team consists of Prof. Josanne Vassallo and Prof. Alex Felice and 
researchers Dr Nikolai Pace and Seham Eljali of the Faculty of Medicine & Surgery at 
the University of Malta. 
ACKNOWLEDGMENT OF RESEARCH SUPPORT
This work is part financed by the Strategic Educational Pathways Scholarship scheme 
grant and by the University of Malta.
THE GENETIC 
EPIDEMIOLOGY OF TYPE 2 
DIABETES IN MALTA
OBJECTIVES OF THE RESEARCH
The immediate objective of our research work is a better understanding of cell-cycle 
involvement in cell survival or programmed cell death. A number of genes which are 
involved in both cell survival and death have been identified, most of which play a 
role at cell-cycle checkpoints. Checkpoints ensure that one phase of the cell cycle is 
complete before a subsequent phase starts, thereby guaranteeing that the daughter 
cells are genetically identical to their parent cell. If checkpoints are non-functional, 
the cell cycle will proceed with damaged DNA, giving rise to defective daughter cells. 
We use yeast cells as experimental models of higher organisms to study aspirin’s 
effect on oxidative stress and programmed cell death.
MAIN FINDINGS TO DATE
Our research team has observed that our redox-compromised yeast cells, which 
resemble cancer cells, die by programmed cell death in the presence of aspirin 
unlike normal, healthy yeast cells. Our studies to date showed key aspirin-induced 
differences in the physiology of the cells between these two sets of yeast cells.
SOCIO-ECONOMIC IMPACT
Aspirin is highly-prescribed to prevent cardiovascular events. However, its preventive 
anti-tumour properties are still not fully understood. Thus, our studies help to 
better understand the mechanisms by which aspirin distinguishes between cancer 
and normal cells and selectively targets cancer cells. The studies may allow for the 
development of better aspirin-like drugs or novel anti-cancer therapies.
THE RESEARCH TEAM
The research team consists of the project leader Prof. Rena Balzan, Research 
Support Officer III Dr. Gianluca Farrugia and Ph.D. student Ms. Maria Azzopardi. 
Institutions contributing to this research work include the Genomic’s Core Facility at 
the European Molecular Biology Laboratory (EMBL) at Heidelberg, Germany and the 
Institute for Molecular Biosciences, Karl-Franzens University of Graz in Austria.
ACKNOWLEDGMENT OF RESEARCH SUPPORT
This work is part of project R&I-2015- 001, which is financed by the Malta Council for 
Science & Technology through the R&I Technology Development Programme.
THE CELL CYCLE IS CRUCIAL 
FOR CELL SURVIVAL
AND DEATH
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OBJECTIVES OF THE RESEARCH
Alzheimer’s disease (AD) and Parkinson’s disease (PD) are devastating illnesses that 
are currently incurable. Combined they afflict around 8 million people in Europe: AD 
leads to severe memory loss (dementia) whilst PD results in uncontrollable tremors 
and slowness of movement. The objective is to discover new drugs for the prevention 
and/or treatment of these neurodegenerative maladies. Specifically, we seek to block 
a key molecular interaction between toxic aggregates and mitochondria, the so-called 
‘powerhouses’ of brain cells.
MAIN FINDINGS TO DATE
We have shown that toxic amyloid aggregates that form in the brains of AD/PD 
patients damage the mitochondria of brain cells by attacking a lipid molecule known 
as cardiolipin in the mitochondria’s double-membrane. Furthermore, we have 
identified 3 naturally-occurring compounds and a marine plant extract that exhibit 
strong anti-aggregate activity for preventing mitochondrial damage.
SOCIO-ECONOMIC IMPACT
Our research could result in the discovery of new therapeutic strategies for 
preventing or slowing the progression of Alzheimer’s and Parkinson’s disease. A 
new effective treatment could improve the quality of life of millions of patients, and 
alleviate the burden on caregivers.
THE RESEARCH TEAM
The research team is led by Dr Neville Vassallo in collaboration with Dr Ruben Cauchi 
of the Department of Physiology & Biochemistry and the Centre for Molecular 
Medicine and Biobanking of the University of Malta.  Current team members are Dr 
Mario Caruana, Michelle Briffa, Angelique Camilleri and Stephanie Ghio.  Past team 
members include research students Alison Gauci, Claire Zarb, Dr Johanna Neuner 
and Ulrike Ostermeier of the University of Munich, Germany.
ACKNOWLEDGMENT OF RESEARCH SUPPORT
The research has been supported by two RTDI programs from the Malta Council of 
Science & Technology (R&I-2008-068 ‘NEUROAMYLOID’ and R&I-2012-066 ‘MODiFLY’). 
Additional funding has been provided by the University of Malta (PHBR-06) and the 
Faculty of Medicine & Surgery (MDSIN08-21).
DISCOVERING NEW DRUGS 
FOR ALZHEIMER’S AND 
PARKINSON’S DISEASES
OBJECTIVES OF THE RESEARCH
Stroke is the third most common cause of death in men and the second most 
common in women according to the World Health Organization (WHO).  In Malta 
10.4% of all deaths were due to stroke.  It is also the most common cause of severe 
disability with 1 in 4 men and 1 in 5 women expected to have a stroke by age 85.  
Current treatment options are extremely limited. Hence, there is a great need for 
new treatment strategies. Our goal is to better understand the mechanisms of 
astrocyte function in order to develop new treatments for stroke.
MAIN FINDINGS TO DATE
Brain function is maintained by an integrated system consisting of specialised cells 
called astrocytes.  Contrary to published reports, we show that astrocytes are more 
vulnerable to injury than previously reported using new laser imaging techniques 
with improved resolution to study the brain in vivo. We have discovered that there 
are subclasses of astrocytes within the same region of the brain exhibiting different 
vulnerabilities to stroke.
SOCIO-ECONOMIC IMPACT
Despite major advances in prevention and rehabilitation, few neurological injuries 
are as debilitating as stroke. Our research is providing new insight into astrocytes and 
could result in more effective treatment.
THE RESEARCH TEAM
The stroke research team consists of Prof. Mario Valentino (Department of 
Physiology & Biochemistry) and researchers Dr Christian Zammit, Jasmine Vella and 
Robert Zammit in collaboration with Prof. Robert Fern and exchange students from 
the University of Plymouth.
ACKNOWLEDGMENT OF RESEARCH SUPPORT
The research is financially supported by the University of Malta Research and through 
collaborations with the University of Plymouth part-funded by the Research Councils 
UK.
IN VIVO IMAGING AND 
MONITORING ASTROCYTES 
IN HEALTH AND DISEASE
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OBJECTIVES OF THE RESEARCH
Spinal Muscular Atrophy (SMA) and Amyotrophic Lateral Sclerosis (ALS) are motor 
neuron diseases that deprive patients of their ability to walk, eat or breathe. While 
ALS occurs in adults, SMA affects young children. Both SMA and ALS patients 
have a deficiency of the Survival Motor Neuron (SMN) protein that results in the 
death of motor neurons and the associated muscles. Using the fruit fly Drosophila 
melanogaster as a model organism, we are learning how the SMN protein works in 
the neuromuscular system of living organisms.
MAIN FINDINGS TO DATE
The SMN protein is involved in the assembly that cuts and pastes the cell’s genetic 
instructions together. We discovered that disruption of this function leads to the 
collapse of the neuromuscular system of fruit flies in a similar manner to SMN 
deficiency. This breakthrough discovery implies that failure to correctly process the 
genetic blueprint for the production of functional proteins could be the reason for 
the neuromuscular deficits in SMA or ALS.
SOCIO-ECONOMIC IMPACT
Current therapies for SMA or ALS are based on boosting SMN protein levels. 
Broadening the therapeutic targets is essential for an effective treatment. Model 
organisms such as the fruit fly are key tools for the successful implementation of this 
strategy.
THE RESEARCH TEAM
The team is led by Dr Ruben J. Cauchi and postgraduate students Michelle Briffa and 
Rebecca Borg and undergraduate students Maia Lanfranco, Benji Fenech Salerno 
and Rebecca Cacciottolo in collaboration with Dr. Neville Vassallo’s research group, 
the French National Centre for Scientific Research (CNRS) and the Institute of Cellular 
Pharmacology Ltd.
ACKNOWLEDGMENT OF RESEARCH SUPPORT
This research is supported by the University of Malta, the Faculty of Medicine & 
Surgery, and the Malta Council for Science & Technology (MCST).
GENETICALLY MODIFIED 
FRUIT FLIES FOR STUDYING 
MOTOR NEURON DISEASE
OBJECTIVES OF THE RESEARCH
One of the most remarkable dimensions of humankind is the brain. The brain is 
responsible for both our normal healthy and unhealthy behaviour. This tempts one 
to ask the question: but how? The brain is composed of billions of ‘micro’ power 
stations, called neurons that generate complex electrical activity patterns. In our 
studies, we are attempting to understand behaviour and its abnormal facets in 
neurodevelopmental conditions, such as ADHD, by analysing the brain electrical 
activity called neural oscillations. This research will further our understanding of the 
neural basis that sub-serves ADHD, and provide insight into the therapeutic effects 
elicited by psychostimulant medication.
MAIN FINDINGS TO DATE
We have discovered that neural oscillations are crucial during mental process 
involved in understanding or the senses and that abnormal neural oscillation can 
distinguish between ADHD and healthy subjects.  Furthermore, we have learned that 
psychostimulant medication improves the abnormal neural oscillations in ADHD.
SOCIO-ECONOMIC IMPACT
We envision that brain signals can be used as objective biomarkers to diagnose 
ADHD rather than ‘paper and pencil’ clinical questionnaires.  In the future, brain 
signals may be used to assist practitioners in the administration of psychostimulant 
medication. 
THE RESEARCH TEAM
The research team consists of Prof. Richard Muscat & Dr Nowell Zammit and 
colleagues at the Centre for Biomedical Cybernetics at the University of Malta. 
ACKNOWLEDGMENT OF RESEARCH SUPPORT
The research is financially supported by the Department of Physiology and 
Biochemistry of the Faculty of Medicine and Surgery at the University of Malta. 
BRAIN FUNCTION AND 
NEURAL OSCILLATIONS
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OBJECTIVES OF THE RESEARCH
A fundamental goal of neuroscience research is to describe the dynamics of human 
cortical activity during cognitive tasks in real time. In this study, we employed stereo-
electroencephalography (sEEG) – a high temporal resolution technique – in order to 
assess the neural activity of patients during tool action observation. We recorded the 
neural activity of 49 epileptic patients implanted with intracerebral electrodes, while 
they observed tool and hand actions. We assessed how different regions of the brain 
respond to the different events in the stimuli.
MAIN FINDINGS TO DATE
Observing tool action onset activated the action observation network but also, unlike 
hand action, a specific region in the left rostral inferior parietal lobule (aSMG). The 
final contact between the effector and the target object triggers activity in areas SII 
and premotor cortex.
SOCIO-ECONOMIC IMPACT
The absence of temporal resolution in imaging techniques has hindered the 
acquisition of four-dimensional maps of human neural activity. Here we show how 
monitoring the timing of cortical brain events during observation task allows for a 
better understanding of how the brain functions. 
THE RESEARCH TEAM
This research team is led by Prof. Giacomo Rizzolatti, Dr Fausto Caruana and Dr 
Pietro Avanzini in collaboration with Prof. Giorgio Lo Russo, Dr Ivana Sartori, and Prof. 
Guy A. Orban affiliated with the Surgical Center for Epilepsy in Ospedale Niguarda, 
Milan and the Department of Neuroscience, University of Parma.  Prof. Giacomo 
Rizzolatti is at the Department of Physiology and Biochemistry, University of Malta 
and at CNR Center of the University of Parma.
ACKNOWLEDGMENT OF RESEARCH SUPPORT
This research is supported by the Cariparma Foundation and a European Research 
Grant (ERC).  
DECOMPOSING TOOL 
ACTION OBSERVATION BY 
sEEG
OBJECTIVES OF THE RESEARCH
Epilepsy is a widespread neurological disease affecting 1% of the world population 
(about 2000 people in Malta). Many epilepsy patients are resistant to traditionally 
drug treatments or suffer from serious drug-induced side effects.  Therefore, 
novel therapeutic approaches are desperately needed for controlling epilepsy 
and improving patients’ quality of life. This project is investigating whether a novel 
technique, called optogenetics, can be used to treat epilepsy. Optogenetics uses light 
of different wavelengths to either stimulate or block nerve impulses of neurons that 
carry light-sensitive proteins.
MAIN FINDINGS TO DATE
We have shown that a fibre optic implanted in the brain can deliver light pulses that 
block the abnormal activity of select neurons.  We have developed a “closed-loop” 
system for controlling the flow of light impulses. Our prototype detects the brain 
electrical activity associated with an epileptic seizure within one tenth of a second. 
This “warning” signal is sent into the fibre optic and delivers a light pulse to the 
selected neurons. Preliminary results show that our prototype system is capable of 
stopping 100% of seizures without any external human intervention.
SOCIO-ECONOMIC IMPACT
Our research could result in an alternative treatment to brain surgery for epileptic 
patients who do not respond well to standard treatments with anti-epileptic drugs. 
Moreover, the new method could be useful for treating epileptic patients who have to 
stop taking anti-epileptic drugs due to adverse side-effects.  
THE RESEARCH TEAM
The team consists of Prof. Vincenzo Crunelli in collaboration with Prof. Giuseppe Di 
Giovanni of the Department of Physiology and Biochemistry, Faculty of Medicine and 
Surgery, University of Malta), Dr Adrian Attard Trevisan (AAT Research Ltd., Malta) and 
Dr Magor Lorincz (University of Szeged, Hungary) and post-doctoral researchers Drs 
Gabriele Deidda, Francois David and Gergely Orban and PhD students Liad Baruchin, 
Maria Vella and Francis Delicata.
ACKNOWLEDGMENT OF RESEARCH SUPPORT
This work is supported by a European Union research grant and MCST project grant 
(R&I-2013-014) “Closed-loop Serotonin Optogenetic Stimulation with EEG recording to 
Suppress Epileptic Seizures: A Therapeutic Device”. 
TREATING EPILEPSY
WITH LIGHT
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OBJECTIVES OF THE RESEARCH
The objectives of our research are to uncover disease causing mechanisms and 
potential therapies for several channelopathies. Recently, we uncovered a distinct 
ion channel-dependent disease characterized by ASD/ID, epilepsy and motor 
impairment. We are studying a large number of these patients, characterizing 
their phenotypes thoroughly and, analysing the presence of mutations in some 
inwardly-rectifying potassium channel types By using advanced electrophysiological, 
biochemical and confocal microscopy technologies, we will investigate the effects of 
mutations on channel activity, protein trafficking, calcium signals, astrocyte\neuron 
interaction and test drugs that are expected to ameliorate the symptoms.
MAIN FINDINGS TO DATE
The genetic mutations in Kir2.1 and Kir4.1 channels and their molecular 
consequences have been partially clarified by our research team, which has provided 
new insight into the pathophysiology of both ASD/ID and epilepsy. By altering the 
channel properties, the identified mutations emerge as potentially deleterious for the 
functions of astrocytes and neurons in the brain.
SOCIO-ECONOMIC IMPACT
The outcome of our research is to transfer the knowledge and technology to clinical 
practice in order to advance diagnosis and improve cost-effectiveness. Families at 
risk will greatly benefit from our investigations as medical practitioners will help them 
preventing this channelopathy and sudden deaths, planning future pregnancies, 
predicting the clinical course of their affected child and getting the right therapy. 
THE RESEARCH TEAM
The research team consists of Dr Maria Cristina D’Adamo (co-ordinator of the project) 
in collaboration with the University of Malta, and Dr Federico Sicca from University 
of Pisa and Dr Elena Ambrosini from the Istituto Superiore di Sanita, Rome. Scientists 
from Boston Children’s Hospital of the Harvard Medical School have recently joined 
our team.
ACKNOWLEDGMENT OF RESEARCH SUPPORT
This research programme is currently funded by the University of Malta and 
Fondazione Cassa di Risparmio di Perugia, Italy.  
AUTISM SPECTRUM 
DISORDER WITH 
INTELLECTUAL DISABILITY
OBJECTIVES OF THE RESEARCH
Brain diseases can affect anyone. One in three Maltese citizens and about 1 billion 
people worldwide suffer from some form of mental condition or disease. Depression, 
addiction and epilepsy, in particular, are amongst the most challenging public 
health issues in the 21st century. We are using  electrophysiological behavioural 
and neurochemical approaches and animal models to study better  understand the 
pathophysiology of these brain diseases with the aim of identifying new drug targets.
MAIN FINDINGS TO DATE
We have discovered one of the mechanisms involved in the antidepressant activity 
of the recreational drug Ketamine and that an area of the brain known as the Lateral 
Habenula is a potential new target for nicotine cessation therapies.  In addition we 
found that marijuana, alcohol and cigarette smoking during childhood can induce 
long-term pathological brain changes as they become in adults. Lastly, we have 
discovered that increasing the levels of cannabinoids and serotonin can be used to 
treat epilepsy.
SOCIO-ECONOMIC IMPACT
Neuropsychiatric disorders have a high economic burden on society due to the 
debilitating health conditions. Although multiple therapies are currently available, 
most of patients are resistant to drug treatment. Our aim is to understand the direct 
neurobiological mechanisms involved in neuropsychiatric disorders, which will help 
us develop more efficacious treatments patients worldwide.
THE RESEARCH TEAM
The research projects are led by Prof. Giuseppe Di Giovanni of the University of 
Malta in collaboration with Dr Massimo Pierucci, Dr Roberto Colangeli, Dr Gergely 
Orban and Dr Gabriele Deidda and research students Francis Delicata, Maria Vella 
and Norbert Abela of the University of Malta; Prof. Vincenzo Crunelli and research 
exchange students of Cardiff University; Dr Maurizio Casarrubea, Prof. Arcangelo 
Benigno and Prof. Giuseppe Crescimanno of the University of Palermo and Dr Adrian 
Attard Trevisan of AAT Research Ltd.  
ACKNOWLEDGMENT OF RESEARCH SUPPORT
The research is supported by the Malta Council for Science & Technology (R&I-
2013-014), the University of Malta and the COST action CM1103. UK students are 
supported by ERASMUS plus. 
CURING DEPRESSION, 
ADDICTION AND EPILEPSY
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Malta Life Sciences Park promotes research and development to spur the growth of 
the Life Sciences Sector in Malta.  MLSP offers 8000 m2 of offices and laboratories in 
a stimulating environment for knowledge-intensive companies.  MLSP also supports 
and encourages commercial growth and success amongst its tenants by offering 
business and financial advice as well as assistance for technology development and 
internationalisation. 
AAT
MENTE is a medical device developed to remove unwanted Delta and Theta 
brainwaves associated with autism. The device uses neurological data to create 
an inverse feedback signal using a state-of-the-art circuitry and noise-cancelling 
technology to suppress excessive Delta and Theta activity.  This system is intended 
for children.  The technology has been developed by Dr. Adrian Attard Trevisan and 
his team.
ELTY FOOD
A collaboration of highly experienced food specialists is establishing a database 
of properties of local food products which forms the basis of their intrinsic food 
research.  They offer laboratory services including food chemistry analysis and 
pesticide residue level analysis.  Elty Food helps the food producer with recipe 
development to ensure that his product is safe and healthy.  The effort is being led by 
Ms. Jeanette Cameron.
MELISSA
A medical device this is being developed and commercialised that is clinically 
effective to treat wounds.  The device is based on the healing properties of Maltese 
honey which has been clinically tested in Switzerland.  Work now includes innovative 
methods to fine tune the formulation and ensure consistency of the device.  The 
technology was developed by Mr. Ray Sciberras.
MALTA LABORATORIES NETWORK
The collaboration effort in the Network has seen the introduction of the Touch-
DNA methodology where epithelia skin cells are used for DNA identification.  This 
methodology is opening up a world of possibilities which links perpetrators’ clothing 
to crime scenes.  The Malta Police Crime Scene Investigation utilise the locally based 
accredited BioDNA Laboratory services.  This technology implementation is being led 
by Dr. Marisa Cassar and Inspector Charlot Casha and their teams.
RESOLVE
A novel solvent recycling machine is being designed and developed for industry to 
recycle solvent waste.  The project funded by MCST RTDI 2014-026T and led by Dr. 
Stefan Mohnani is intended to be energy efficient in order to make it commercially 
viable.
 MLSP is a Malta Enterprise project that was partially funded by ERDF 199 and ERDF 
331 (ERDF 2007-2013).    
MALTA LIFE 
SCIENCES PARK
OUR MANDATE
The MCAST Water Research and Training Centre was established in 2013 to provide a 
national focal point for the research and skills related to the themes of potable water, 
grey water and sea water/coastal waters.  The Centre works in close collaboration 
with MCAST’s Centre for Agriculture and the Institutes of Applied Sciences and 
Engineering & Transport.
OUR VISION
Malta has the lowest water resources index and the highest water competition index 
in the whole of the Mediterranean basin. It is thus imperative that Malta be at the 
forefront of water technology and in the research and development of complex 
water systems. The MCAST Water Research and Training Centre focuses on water 
enterprise, aiming to embody the application of creative ideas and innovation to 
practical solutions in the fields of potable water and grey water.  Research and 
innovation within this Centre focus on the themes of water systems control, water 
efficiency and innovation and water quality enhancement.
OUR ACHIEVEMENTS
Main research thrusts of the Centre are targeted at grey water micro-solutions, 
apparent water loss control and the descaling of water.  As an example, an innovative 
grey water micro-system is being run by the Centre in collaboration with Alter Aqua, 
to study the effects of specifically treated drains water on the growth of plants in 
a green-roof setup.  Recent results indicate that various indigenous plants can be 
grown in a micro-environment with this ‘dirty’ water.  Another research initiative 
has focused on innovative magnetic technologies for the descaling of water within 
commercial treatment plants.
WATER PARTNERSHIPS
The water research is strongly supported by a number of EU and local funding 
grants such as the ERDF funding of the Centre’s laboratories, lead partnership in a 
Horizon2020 project focusing on water utilization in agriculture, and local funding 
from MCST Fusion and the Global Water Partnership.  The research is run by a team 
of MCAST lecturers, scientists, engineers and undergraduate students. A high level of 
collaboration exists with CIWEM, the IWA, CIHEAM, Cranfield University, the WSC, and 
SEWCU.
ENTERPRISING WATER 
SOLUTIONS
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OUR MANDATE
The Research Trust of the University of Malta (RIDT) was established in 2011 as a key 
component of Malta’s efforts to bolster investment in research and development 
on a national level. RIDT was set up specifically to engage with the community and 
encourage its various sectors to embrace the emerging need of supporting research 
at the University of Malta.
OUR VISION
Malta’s future, like any progressive nation’s lies in the ability to innovate and discover 
new aspects of human development. Investing in Malta’s future is akin to investing in 
each and every citizen’s future. RIDT has embarked on a new path, where individuals, 
businesses and organisations dare to dream of a new way forward for Malta in a 
unique partnership across public, private and social sectors.
OUR ACHIEVEMENTS
In the few years since its inception, RIDT has attracted broad ranging support from a 
number of sectors, thereby providing a tangible and much needed impetus for high-
calibre R&D projects across various faculties and departments within the University 
of Malta, be it projects in engineering and technology, physical and life sciences, 
medicine, humanities, social sciences and the arts.
The Maltese community has responded to our appeal by financing a number of 
research initiatives including PhD scholarships in cancer research, a programme in 
kidney research, a nation-wide survey on diabetes, industrial research, studies in 
economics, osteoporosis, digital marketing, ICT and linguistics. 
See more on our website: www.ridt.eu
THE UNIVERSITY OF MALTA
MOBILE DENTAL CLINIC
This novel community project reaches out to all sectors of society including the 
underprivileged, the institutionalised, schools, orphanages and the homebound. 
While providing oral health advice and dental care, the project collects 
epidemiological data relating to the Maltese population. This project has been 
achieved thanks to the support of a number of corporate entities through RIDT.
RESEARCH, INNOVATION 
AND DEVELOPMENT TRUST 
(RIDT)
OUR MANDATE
The Medicines Authority is a science and health oriented competent authority 
based on the values of quality, innovation, people and integrity.  Our mission is to 
protect and enhance public health through the regulation of medicinal products and 
pharmaceutical activities.
OUR VISION
Our vision is to be a centre of excellence in advancing effective and innovative 
regulation and promoting quality and scientific rigour in the work we do. We strive 
to be a best in class regulator for the benefit of patients and stakeholders.  We 
endeavour to be an internationally recognised, efficient entity and promoter of 
people development and sustainable growth.
ACHIEVEMENTS
Safe, Efficacious and Quality Medicines for the Benefit of the Patients
• Over 5300 medicinal products registered, with over 450 products having been 
registered between January and August 2016. 
• Top 5 position in the EU in the assessment of generic medicines at centralised level 
and assessing over 250 medicinal products as Reference Member State.
• Establishment of Medicines Intelligence and Access Unit.
Effective and Innovative Regulation
• Conducting EU Good Manufacturing Practice Inspections in India, China, Serbia and 
Ukraine, establishing Malta as a hub for the pharmaceutical and life sciences sectors 
in Europe. 
• First agency to deliver joint scientific advice with another Member State so as to 
facilitate accelerated access to medicines. 
• Collaboration with the MEB of the Netherlands to start outsourcing part of its 
assessment work to Malta.
Achieving Results through People, Good Governance and Innovation
• Introduction of the Medicines Authority International Traineeship Programme and 
over 30% of employees carrying out studies at Masters and Doctoral level.
• An established and certified Quality Management System.
• Relocation to the strategic and scientific environment of the Malta Life Sciences Park 
leading to cost savings. 
MALTA MEDICINES 
AUTHORITY
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